Logo image of CEVA

CEVA INC (CEVA) Stock Fundamental Analysis

USA - NASDAQ:CEVA - US1572101053 - Common Stock

26.64 USD
-1.82 (-6.39%)
Last: 10/17/2025, 8:01:17 PM
27.15 USD
+0.51 (+1.91%)
After Hours: 10/17/2025, 8:01:17 PM
Fundamental Rating

4

CEVA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CEVA as it has an excellent financial health rating, but there are worries on the profitability. CEVA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CEVA was profitable.
CEVA had a positive operating cash flow in the past year.
CEVA had negative earnings in 4 of the past 5 years.
CEVA had a positive operating cash flow in 4 of the past 5 years.
CEVA Yearly Net Income VS EBIT VS OCF VS FCFCEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of CEVA (-3.33%) is worse than 62.50% of its industry peers.
Looking at the Return On Equity, with a value of -3.79%, CEVA is doing worse than 60.71% of the companies in the same industry.
Industry RankSector Rank
ROA -3.33%
ROE -3.79%
ROIC N/A
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
CEVA Yearly ROA, ROE, ROICCEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

The Gross Margin of CEVA (86.49%) is better than 99.11% of its industry peers.
CEVA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
CEVA Yearly Profit, Operating, Gross MarginsCEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
CEVA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CEVA has been increased compared to 5 years ago.
There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CEVA Yearly Shares OutstandingCEVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CEVA Yearly Total Debt VS Total AssetsCEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CEVA has an Altman-Z score of 12.01. This indicates that CEVA is financially healthy and has little risk of bankruptcy at the moment.
CEVA's Altman-Z score of 12.01 is fine compared to the rest of the industry. CEVA outperforms 76.79% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.01
ROIC/WACCN/A
WACC11.56%
CEVA Yearly LT Debt VS Equity VS FCFCEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 8.58 indicates that CEVA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 8.58, CEVA belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
CEVA has a Quick Ratio of 8.58. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.58, CEVA belongs to the top of the industry, outperforming 94.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.58
Quick Ratio 8.58
CEVA Yearly Current Assets VS Current LiabilitesCEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

6

3. Growth

3.1 Past

CEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.33%, which is quite impressive.
The Earnings Per Share has been decreasing by -8.60% on average over the past years.
The Revenue has been growing slightly by 7.71% in the past year.
The Revenue has been growing slightly by 4.17% on average over the past years.
EPS 1Y (TTM)58.33%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%-58.82%
Revenue 1Y (TTM)7.71%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%-9.7%

3.2 Future

Based on estimates for the next years, CEVA will show a very strong growth in Earnings Per Share. The EPS will grow by 38.80% on average per year.
CEVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y22.18%
EPS Next 2Y43.16%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue Next Year3.98%
Revenue Next 2Y9.59%
Revenue Next 3Y9.67%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CEVA Yearly Revenue VS EstimatesCEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
CEVA Yearly EPS VS EstimatesCEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 70.11, CEVA can be considered very expensive at the moment.
CEVA's Price/Earnings ratio is in line with the industry average.
CEVA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
Based on the Price/Forward Earnings ratio of 35.13, the valuation of CEVA can be described as expensive.
CEVA's Price/Forward Earnings ratio is in line with the industry average.
CEVA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 70.11
Fwd PE 35.13
CEVA Price Earnings VS Forward Price EarningsCEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEVA Per share dataCEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CEVA's earnings are expected to grow with 38.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.16
PEG (5Y)N/A
EPS Next 2Y43.16%
EPS Next 3Y38.8%

0

5. Dividend

5.1 Amount

CEVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEVA INC

NASDAQ:CEVA (10/17/2025, 8:01:17 PM)

After market: 27.15 +0.51 (+1.91%)

26.64

-1.82 (-6.39%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-11 2025-08-11/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners95.1%
Inst Owner Change0.02%
Ins Owners3.42%
Ins Owner Change15.6%
Market Cap636.16M
Analysts81.67
Price Target32.47 (21.88%)
Short Float %9.37%
Short Ratio7.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8%
Min EPS beat(2)-15.97%
Max EPS beat(2)31.98%
EPS beat(4)2
Avg EPS beat(4)14.27%
Min EPS beat(4)-15.97%
Max EPS beat(4)41.21%
EPS beat(8)4
Avg EPS beat(8)50.88%
EPS beat(12)5
Avg EPS beat(12)17.52%
EPS beat(16)9
Avg EPS beat(16)15.46%
Revenue beat(2)0
Avg Revenue beat(2)-5.36%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-0.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)3.96%
Revenue beat(8)2
Avg Revenue beat(8)-2.15%
Revenue beat(12)3
Avg Revenue beat(12)-5%
Revenue beat(16)6
Avg Revenue beat(16)-4.94%
PT rev (1m)0%
PT rev (3m)-6.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-26.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 70.11
Fwd PE 35.13
P/S 5.98
P/FCF N/A
P/OCF 286.56
P/B 2.39
P/tB 3.09
EV/EBITDA N/A
EPS(TTM)0.38
EY1.43%
EPS(NY)0.76
Fwd EY2.85%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.09
OCFY0.35%
SpS4.45
BVpS11.13
TBVpS8.63
PEG (NY)3.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.33%
ROE -3.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.49%
FCFM N/A
ROA(3y)-4.76%
ROA(5y)-2.99%
ROE(3y)-5.58%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.67%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.62%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.58
Quick Ratio 8.58
Altman-Z 12.01
F-Score6
WACC11.56%
ROIC/WACCN/A
Cap/Depr(3y)65%
Cap/Depr(5y)55.38%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3Y-17.12%
EPS 5Y-8.6%
EPS Q2Q%-58.82%
EPS Next Y22.18%
EPS Next 2Y43.16%
EPS Next 3Y38.8%
EPS Next 5YN/A
Revenue 1Y (TTM)7.71%
Revenue growth 3Y-4.48%
Revenue growth 5Y4.17%
Sales Q2Q%-9.7%
Revenue Next Year3.98%
Revenue Next 2Y9.59%
Revenue Next 3Y9.67%
Revenue Next 5YN/A
EBIT growth 1Y-8.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.3%
EBIT Next 3Y100.68%
EBIT Next 5YN/A
FCF growth 1Y96.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.74%
OCF growth 3Y-48.76%
OCF growth 5Y-18.53%